In Brazil, two recent events highlighted challenges and opportunities for psychedelic therapies in mental health. The most recent was the 16th Symposium on Psychobiology, which discussed integrating psychedelics into Brazil’s public health system (SUS), emphasizing communal and therapeutic contexts over reductionist models. Experts called for political support, Indigenous wisdom, and innovative research to counter stigma and regulatory hurdles.